CELL2B-ADVANCED THERAPEUTICS SA

Company Summary

The company CELL2B-ADVANCED THERAPEUTICS SA is a Joint Stock Company, established in Thursday, December 30, 2010, with headquarters in the municipality of CANTANHEDE. The share capital is 55.999,44 € , and its Economic Activity Code (CNAE) is 72101 Biotechnology research and development
In the sector corresponding to this CAE with an average EBITDA of 149.948,94 € (profit before depreciation, amortization, financing expenses and taxes).
The average payment term recorded in this sector was 123 days.

Status from Cell2B-Advanced Therapeutics Sa

Inactive

Sales Evolution in the Company

Undefined

Commercial Incidents

Legal Actions (Defendant/Plaintiff)

Tax Authority Debts

Social Security Debts

Insolvencies

Public Execution List

Profile Report - 15€
Available Balance Sheets

2018, 2017, 2016

Financial Report 27€

Company reports Cell2B-Advanced Therapeutics Sa